It was around five in the morning on April 1, 2025, when Antoine Archambault woke to the sound of his four-month-old son, Isaac, making soft noises from the crib in their Paris apartment. His whimper was typical for a baby, especially one so cheerful. Isaac had a slight fever, which Antoine treated with paracetamol, and soon he settled back into sleep, snug in his little sleep sack.
Antoine hoped to catch a few more winks, but Isaac stirred again. The fever hadn’t subsided. Since Claire Fauvet, Antoine’s partner and Isaac’s mother, had an early train to catch for work, Antoine decided to take Isaac for a short walk to the nearby clinic. They arrived just as it opened at 8 a.m., expecting a routine checkup. It was a rude awakening when the staff called an ambulance, explaining that Isaac might have meningococcal disease.
Meningococcal disease is a terrifying prospect for both pediatricians and informed parents. It’s caused by the bacterium Neisseria meningitidis, which can invade the bloodstream or spinal cord and is often transmitted through close contact with respiratory secretions. While many harbor it harmlessly, it can, in some cases, escalate into a serious infection, presenting flu-like symptoms that can rapidly devolve into dire conditions. Statistics indicate that 10 to 15 percent of those infected may die, even with quick medical intervention, and many survivors endure lasting physical or cognitive issues.
Antoine was somewhat familiar with meningococcal disease; he recalled a documentary about a swimmer whose childhood illness had devastating effects. He had always believed that Isaac was protected due to the diligent vaccinations he and Claire ensured for their child. Texting Claire with the news, he noted, “They think it’s meningitis, but wasn’t he vaccinated?” She confirmed he had received his shots.
However, France’s vaccination schedule, which lists the vaccines required for childcare and school, hadn’t included one of the two meningococcal vaccines until just recently. A new mandate for this second shot only took effect on January 1, following Isaac’s birth, meaning his appointment was still weeks away. As a result, Isaac was exposed to potential carriers in the community, and sadly, one must have transmitted it to him.
The chaos of the next few hours is a blur for Antoine. He described losing his sense of stability, feeling weak, emotionally shaken to the core. Less than a day before, he had been laughing and playing with Isaac at a café, coaxing a smile with a musical stuffed monkey. Claire had rocked Isaac to sleep that evening, and he appeared perfectly healthy. Now, doctors were putting him into a medical coma, which they believed was his best chance at survival.
Claire returned to Paris swiftly, and for a while, it seemed that Isaac was improving. His vital signs showed promise. However, that hope was fleeting; his condition worsened quickly.
Isaac’s heart stopped three times. The medical team revived him after the first two episodes, but after the third, they could not bring him back. He passed away at 6:35 p.m.
Earlier this month, Health and Human Services Secretary Robert F. Kennedy Jr. announced changes at the CDC regarding recommended vaccinations for American children, removing several, including the newer meningococcal vaccine known for its excellent safety record. This shot has contributed to a significant drop in disease incidence in the U.S.
The updated recommendations now restrict the meningococcal vaccine to high-risk groups, leaving it to the discretion of parents whether to vaccinate their children after consulting with healthcare providers. It’s unclear how much this will change, as states will still determine school vaccination requirements, and insurers will continue covering vaccines.
These recommendations greatly influence decisions made by physicians, state officials, and insurers. Thus, the changes to vaccination protocols carry significant weight, especially among those skeptical of vaccines. The latest adjustments in policy weren’t made based on new research; instead, they came from a reassessment ordered by President Donald Trump to align U.S. recommendations with those from peer nations.
Such claims about a global consensus aren’t entirely accurate. Actually, vaccine guidelines vary widely across Europe and North America. Before this shift, the U.S. had one of the most comprehensive vaccination schedules, recommending immunizations for seventeen diseases. Now, it drops to twelve, a figure closely resembling that of Denmark, which has often been cited by the Trump administration.
It’s ironic that Denmark—a small country—is being held as a model when discussing a public health issue that has much broader implications. A more comprehensive review would have included larger nations, like France, that have been actively engaged in vaccine-related debates.
France’s experience, particularly regarding meningococcal vaccines, sheds light on broader discussions. It has a significant economy and population, resembling the U.S. in various ways, including health care access. Additionally, France has a notable anti-vaccination movement rooted in political skepticism, presenting a different approach to vaccine policies compared to other nations.
Over the last two decades, public pressure has led France to mandate more vaccines as health experts feared dipping vaccination rates could jeopardize herd immunity. However, the new meningococcal vaccine was initially overlooked, based on historical assessments of cost versus disease rarity. Recently, though, as cases of the disease rose, authorities acknowledged the urgency and included the vaccine in the mandatory list.
This approach stands in stark contrast to the one adopted by the Trump administration, which favors voluntary vaccinations followed by outbreaks intervention. The review that justified such a shift seems to have overlooked the recent developments from France, prioritizing a singular narrative without adequate analysis.
In a system like the U.S.’s, funding is abundant for life-saving interventions. Experts like Rochelle Walensky emphasize the importance of preventing diseases like meningococcal, especially after witnessing their devastating impact firsthand.
Antoine and Claire have been motivated to take action following Isaac’s death. They’ve raised funds for research into meningococcal disease and worked on training for medical professionals to better recognize it. Spreading awareness about the vaccine has also been a priority for them among friends and colleagues.
Before wrapping up our conversation, Antoine shared cherished photos of Isaac, all showing him grinning just as I had been told. He recounted the quiet memorial service held at the hospital, ensuring their son had his favorite blanket and stuffed monkey. Antoine visits the cemetery regularly, where Isaac rests, a haunting reminder of their profound loss.
